Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Pfizer's Clinical Research Unit Achieves LEED(TM) Certification
Completed in April 2005, Pfizer's 62,000-sf Clinical Research Unit (CRU) in New Haven, Conn., features state-of-the-art, flexible lab and research space for clinical trials of drug certification products and accommodates 50 volunteers and 50 staff. Designed by the architectural firm The S/L/A/M Collaborative of Glastonbury, Conn., and built by Whiting Turner of New Haven, the CRU has been awarded Silver LEED™ certification by the U.S. Green Building Council (USGBC), the first such designation for a building in Connecticut.
Children's Hospital of Philadelphia Plans Research Tower
The Children's Hospital of Philadelphia (CHOP) celebrated the groundbreaking on June 2, 2006 of a $400-million research tower in West Philadelphia. Sited on the former Philadelphia Civic Center site, the 558,000-sf, eight-story facility will accommodate translational research and is slated for completion in spring of 2009. The project is the first phase of the larger plan for the $845-million Children's Hospital's South Campus Research Facility which will spread over nearly eight acres across from CHOP's existing facilities.
Fluor Dedicates New Irving Headquarters
Fluor Corporation dedicated its new global headquarters in Irving, Texas, on June 5, 2006. Housing approximately 180 employees, the 140,000-sf, three-story, dual-wing facility was constructed on a 26-acre property located in the Las Colinas business district. Featuring a commercial kitchen and dining area, employee fitness center, 100-seat auditorium, meeting rooms, a three-story glass-enclosed atrium, and a two-story parking facility, the building was designed and built to meet LEED™ sustainability criteria.
Children's Hospital of Philadelphia Breaks Ground on Translational Research Building
The Children's Hospital of Philadelphia broke ground in early summer of 2006 on a $400-million translational research building on the former Philadelphia Civic Center site. The eight-story, 558,000-sf facility will house four new laboratory floors, administration and conference space, two-story lobby, and a cafeteria.
Bristol-Myers Constructs Biologics Manufacturing Plant
Bristol-Myers will construct a 750,000-sf large-scale biologics manufacturing faciltiy on 85 acres at the former Fort Devens Army Base in Devens, Mass. The $1.1-billion project includes a $660-million capital expenditure by Bristol-Myers to construct a plant for the the manufacturing of biologics compounds including the rheumatoid arthritis treatment Orencia. Construction will begin in September 2006 with completion slated for 2009 and production to begin in late 2011.